The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

Patients with palmoplantar pustulosis have a high disease burden, with younger patients and those with nail involvement having worse quality of life.

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics may also be considered.

While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

Adults with acne were found to be significantly more likely to have an eating disorder, even accounting for comorbid mental health disorders.

Since 1992, research from the ongoing Women's Health Initiative prevented an estimated 126,000 breast cancer cases and produced more than 2400 scientific publications.

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

NIH Director Dr Jay Bhattacharya announced plans for centralizing and expanding the NIH's access to patient data.

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

Pretrained foundation models for diagnosing nonmelanoma skin cancer outperformed baseline machine learning models.

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.